Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Masimo logo — Masimo innovations empower clinicians to transform patient c...

Masimo

Masimo innovations empower clinicians to transform patient care.

Founded 1989 United States Irvine, United States 3534 employees IPO Total: $755.00M Biotechnology, Health Care +2

General Information

Company Name Masimo
Founded Year 1989
Location United States Irvine, United States +1
Employees 3534
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage IPO
Social

Get notified when Masimo moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Masimo

Masimo (NASDAQ: MASI), founded in 1989, is a pioneering force in the Biotechnology, Health Care, Manufacturing, and Medical Devices industries, with a focus on developing innovative noninvasive patient monitoring technologies. Based in the United States, the company is renowned for its clinically-proven products that empower healthcare providers with critical data to optimize clinical decisions.

The company's slogan, "Improving life. Improving patient outcomes and reducing the cost of care," encapsulates its commitment to enhancing patient care and safety. Over its decades-long journey, Masimo has consistently tackled 'unsolvable' problems, building a portfolio that includes advanced medical devices and sensors.

Recently, Masimo secured a significant $750.00M Post-IPO Equity investment on 15 August 2022, led by Politan Capital Management. This investment underscores strong market confidence and positions Masimo for continued innovation and growth in the competitive medical technology landscape.

Taxonomy: Medical Technology, Patient Monitoring, Noninvasive Monitoring, Healthcare Innovation, Clinical Decision Making, Patient Safety, Sensors, Innovative Solutions, Healthcare Outcomes, Cost Reduction, Medical Innovations, Global Impact

Services & Products

Patient Monitoring Systems
Emergency Medical Services Solutions
Healthcare Automation
Remote Monitoring and Notification
Medical Device Integration
Clinical Analytics

Target Customers

Hospitals Healthcare Professionals Emergency Medical Services ICU and NICU Facilities Home Care Providers Contract Research Organizations Government and Military Healthcare Units

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• - 01 Aug 2022
Post Ipo Equity •••••• 1
Investor
01 Aug 2017
Grant •••••• 1
Investor
01 Nov 2016
IPO •••••• - 01 Aug 2007
Unknown •••••• 1
Investor
01 Jul 2000

Latest News

View All
Activist investor plans second fight at Masimo, sending shares up 5% — Cnbc
Activist investor plans second fight at Masimo, sending shares up 5%
Cnbc Mar 25, 2024
Masimo seeks to stave off proxy fight with Politan, makes settlement offer — Cnbc
Masimo seeks to stave off proxy fight with Politan, makes settlement offer
Cnbc May 09, 2024
Masimo activist director Koffey demands ‘basic’ information on company’s proposed spinoff — Cnbc
Masimo activist director Koffey demands ‘basic’ information on company’s proposed spinoff
Cnbc May 10, 2024
Apple Watch getting redesigned blood oxygen feature following legal dispute — Cnbc
Apple Watch getting redesigned blood oxygen feature following legal dispute
Cnbc Aug 14, 2025

Masimo Alternatives & Competitors

Masimo vs
Sentec
Sentec Switzerland

Care with confidence.

368 employees
Manufacturing, Medical Devices
Masimo vs
Biobeat
Biobeat Israel

AI remote patient monitoring platform, measuring 13 vital signs and triggering early clinical interv...

Series A
35 employees
Biotechnology, Data Analytics
Compare Masimo vs Biobeat
Masimo vs
Fifth Eye Inc.
Fifth Eye Inc. United States

FDA cleared software designed to avert crises through early awareness of emerging adverse events.

Series A
14 employees
Digital Health, Health Care
Compare Masimo vs Fifth Eye Inc.
Also compare with: Masimo vs Cercacor Cercacor

FAQ About Masimo

Masimo innovations empower clinicians to transform patient care.
Masimo was founded in 1989.
Masimo is headquartered in Irvine, United States.
Masimo operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.
Masimo has approximately 3534 employees.
Masimo has completed 5 funding rounds, raising a total of $755.00M. The latest funding stage is IPO.
Masimo offers: Patient Monitoring Systems, Emergency Medical Services Solutions, Healthcare Automation, Remote Monitoring and Notification, Medical Device Integration, Clinical Analytics.
Top alternatives and competitors to Masimo include Sentec, Biobeat, Fifth Eye Inc., Curbell Medical, Cercacor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Masimo and Sentec are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Masimo and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy